Analysts' mean price target for Biodesix (BDSX) implies 103.3% upside, indicating a notably bullish consensus on the stock. The article also notes that analysts are raising earnings estimates, which supports a positive outlook despite the general limitations of price-target metrics. Overall, this is supportive commentary rather than a catalyst-driven update.
Analysts' mean price target for Biodesix (BDSX) implies 103.3% upside, indicating a notably bullish consensus on the stock. The article also notes that analysts are raising earnings estimates, which supports a positive outlook despite the general limitations of price-target metrics. Overall, this is supportive commentary rather than a catalyst-driven update.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment